DSCSA-D-Day-PharmaceuticalCommerce_June2022.pdf

Read the full article published in Pharmaceutical Commerce.

For manufacturers who haven’t started preparing for DSCSA D-Day, the “OH NO!” moment is here, but this article can help.

Pharmaceutical Commerce engaged Shannon Hybner from Archbow Consulting to walk the industry through what manufacturers need to be doing now to be prepared for next November’s deadline. Her article includes:

• • An overview of The Act and key expectations for the market
  • What DSCSA really means for manufacturers
  • The differences between aggregation and serialization
  • Recommended next steps for manufacturers
  • Critical upcoming dates to ensure timely compliance
  • Why distributors are pushing up deadlines
  • Next steps

Read Shannon’s article in Pharmaceutical Commerce and contact us if we can be of assistance in helping you meet your DSCSA deadlines. As a pharmaceutical consulting company, Archbow provides strategic guidance and tactical implementation support for various distribution areas, including wholesale, specialty distribution, and 3PL services.

DSCSA-D-Day-PharmaceuticalCommerce_June2022.pdf

Archbow Consulting helps pharmaceutical and biotech companies in the USA and Europe design, build, and optimize product distribution and patient access strategies. Archbow was founded by industry veterans to meet a need in the marketplace for consulting options that offer diverse real-world experience, are able to leverage deep connections across the industry, and can also provide actionable strategic guidance. We invite you to learn more about our team, services, and clients’ success, and connect with us via email, LinkedIn or subscribing to this blog which you can do below.

Share in